Citation
J Haem Pract 2017; 4(1). doi: 10.17225/jhp00101

Authors: Michelle Witkop, Christine Guelcher, Margaret Hall, Jennifer Maahs

Michelle Witkop
Northern Regional Bleeding Disorders Center at Munson Medical Center, 1105 Sixth Street, Traverse City, MI 49684. Email: Mwitkop@mhc.net

Christine Guelcher
Center for Cancer and Blood Disorders, Children’s National Health System, 111 Michigan Avenue, NW, Washington DC, 20010.. Email: Cguelche@childrensnational.org

Margaret Hall
Northern Regional Bleeding Disorders Center at Munson Medical Center, 1105 Sixth Street, Traverse City, MI 49684. Email: Mhall4@mhc.net

Jennifer Maahs
Indiana Hemophilia & Thrombosis Treatment Center, 8326 Naab Road, Indianapolis, IN 46260.. Email: jmaahs@ihtc.org

Abstract

Introduction: As the focus on personalised treatment is refined, more products are brought to market and the life expectancy of persons with haemophilia increases, there will be an expanded need of experienced and expert healthcare providers to ensure optimal patient outcomes.
Aim: This survey describes the demographics, roles/responsibilities, practice patterns, educational opportunities/barriers and employment benefits of nurses and advanced practices providers (APPs), including advanced practice registered nurses (APRNs) and physician assistants (PAs) employed by haemophilia treatment centres (HTCs) across the United States.
Methods: This one-time convenience online survey was approved by the Munson Medical Center Institutional Review Board. A survey of this type had never been attempted in the HTC nursing community; therefore, there was no opportunity to utilise a previous tool. Data was analysed using statistical tools through SurveyMonkey.
Results: Gaps were identified in provider age distribution, research opportunities, and standardized educational opportunities for APPs. An aging but highly educated HTC nursing population is revealed: over 50% of respondents were over the age of 50; the majority held at least a baccalaureate degree and almost half had national board certification; most were experienced in healthcare but newer to the field of bleeding disorders.
Conclusion: Development of an APP fellowship program would standardise the care and treatment of those with bleeding and clotting disorders across the United States. This fellowship should include a didactic portion, advocacy within the community, mentorship with experienced APPs and regular webinar-based case studies to review current trends in care. This survey is a call to action to begin standardized education programs for the advanced practice role.

Acknowledgements

All authors contributed equally to the research design, research analysis and authorship of the manuscript.
Declaration of Interests
Michelle L. Witkop conducted the survey; she has served as a paid consultant to Aptevo, NovoNordisk, Pfizer, Inc, and NHF, and has served on advisory boards for Baxalta, Aptevo, Octapharma, NovoNordisk, and Pfizer, Inc. She has received research funding from Pfizer, Inc. and is on speakers’ bureaus for Aptevo, NovoNordisk, and Pfizer, Inc.
Christine Guelcher has served on advisory boards for Baxalta, Octapharma, NovoNordisk, Grifols, and Biogen. She is on speakers’ bureaus for SolutionSight and NovoNordisk.
Jennifer Maahs and Margaret Hall have no interests to declare.
The authors received no funding or writing assistance with this research/manuscript.

References

  1. Evatt BL. The natural evolution of haemophilia care: developing and sustaining comprehensive care globally. Haemophilia 2006;12: 13-21.
  2. Andoniann AA, Dietrich SL, Whiteman ST. A total program for the patient with hemophilia. I Medical aspects. Journal of American Physical Therapy Association 1966; 46:1268-71.
  3. Boone DC. A total program for the patient with hemophilia. II Physical therapy aspects related to orthopedic and neurologic residuals of bleeding. Journal of American Physical Therapy Association 1966; 46:1272-81.
  4. Hurt C. A total program for the patient with hemophilia. III Psychosocial problems. Journal of American Physical Therapy Association 1966; 46:1282-4.
  5. National Hemophilia Foundation. Comprehensive medical care: HTCs. Available from: https://www.hemophilia.org/Researchers-Healthcare-Providers/Comprehensive-Medical-Care-Hemophilia-Treatment-Centers (accessed 16 February 2017).
  6. Soucie M, Nuss R, Evatt B, et al. Mortality among males with hemophilia: relations with source of medical care. Blood 2000; 96(2): 437-42.
  7. Institute of Medicine. The Future of Nursing: Leading the Change, Advancing Health. Washington, DC: The National Academies Press, 2011. Available from: http://www.nationalacademies.org/hmd/Reports/2010/The-Future-of-Nursing-Leading-Change-Advancing-Health.aspx (accessed 16 February 2017).
  8. Manucci PM, Roberts R. Uncertain times for research on hemophilia and allied disorders. J Thromb Haemost 2005; 3: 423.
  9. Vermylen J. More on: uncertain times for research on hemophilia and allied disorders. J Thromb Haemost 2005; 3: 1547.
  10. Konkle BA. Uncertain times for research in hemophilia and allied disorders. J Thromb Haemost 2006; 4: 681.
  11. Makris M. Uncertain times for research in hemophilia and allied disorders. J Thromb Haemost 2006; 4: 683.
  12. Witkop ML, Adkins S, Hall M, et al. An alternative model of comprehensive care for geographically challenged hemophilia treatment centers in the United States. Poster presented at the World Federation of Hemophilia 2016 World Congress, Orlando, Florida, 24-28 July 2016. Available from: https://www.postersessiononline.eu/pr/congreso.asp?cod=732723414, Poster 122-PP-W (accessed [provide date]).
  13. Hall M, Roessler S, Rushlow D, et al. Cost and time effectiveness of telemedicine to deliver collaborative Hemophilia Treatment Center (HTC) services to remote patients. Haemophilia 2016; 22: (Suppl.4): 13.
  14. Trujillo M, Cheng D, Drake J, et al. A national survey of the 340B pharmacy income program: Quantitative evaluation of the services provided by US Hemophilia Treatment Centers. Haemophilia 2016; 22: (Suppl.4): 15.
  15. American Association of Nurse Practitioners. What’s an NP? Available from: https://www.aanp.org/all-about-nps/what-isan-np/ (accessed 27 April 2017).
  16. American Academy of Physician Assistants. How are PAs educated and trained? Available from: https://www.aapa.org/what-is-a-pa/#tabs-2-how-are-pas-educated-and-trained/ (accessed 27 April 2017).
  17. Manco-Johnson MD, Riske B, Kasper CK. Advances in care of children with hemophilia. Semin Thromb Hemost 2003; 29(6): 587-94.
  18. Schrijvers M, Creveldkliniek V. Current practice survey of European haemophilia nursing care. Haemophilia. 2014; 20(Suppl. 2):18-91. PO051
  19. Harrington C, Bedford M, Andritschke K, et al. A European curriculum for nurses working in haemophilia. Haemophilia. 2016; 22(1): 103-9; doi: 10.1111/hae.12785.
  20. Centers for Disease Control and Prevention Hemophilia Treatment Center (HTC) Directory. Available from: https://www2a.cdc.gov/ncbddd/htcweb/dir_report/dir_search.asp (accessed 27 April 2017).
  21. Partners in Bleeding Disorder Education. [website]. Available from: www.partnersprn.org (accessed 27 April 2017).
  22. Medscape. State CE requirements for nurses. Available from: http://www.medscape.org/public/nursecestaterequirements (accessed 16 February 2017).
  23. Medscape http://www.nursepractitionerschools.com/faq/npvs-physician-assistant (accessed 2/24/16)
  24. Danielson C, Rushton HG. Nonphysician provider fellowship training: Meeting patient needs in a time of physician shortages. J Urol 2011; 365(3): 771-3.
  25. Hart AM, Macnee CL. How well are nurse practitioners prepared for practice: Results of a 2004 questionnaire study. J Am Acad Nurse Pract 2007; 39(1): 35-42.
  26. Sargent L, Olmedo M. Meeting the needs of new-graduate nurse practitioners: a model to support transition. J Nurs Adm 2013; 4.3(11): 603-10.
  27. Whitcomb ME. The shortage of physicians and the future role of nurses. Acad Med. 2006; 63(9): 779-80.
  28. Williams TE, Satiani B, Thomas A, Ellison EC. The impending shortage and the estimated cost of training the future surgical workforce. Ann Surg 2009; 250(4): 590-7.
  29. Witkop M, Cutter S, Deutsche J, et al. Emerging therapies for haemophilia: a new era of care and the role of the interdisciplinary team. Semin Thromb Hemost 2014; 40(7): 790-802.
  30. SurveyMonkey™. How to analyse survey results. Available from: http://help.surveymonkey.com/articles/en_US/kb/Howtoanalyze-results?bc=Understanding_Your_Results (accessed 16 February 201017).
  31. NPI Registry. National Provider Identifier Database. Available from: https://npidb.org/ (accessed 27 April 2017).
  32. Partners in Bleeding Disorders Education. Live Events. Available from: http://partnerspm.org/events/ (accessed 27 April 2017).
  33. US Department of Justice Drug Enforcement Administration, Diversion Control Division. Title 21 United States Code (USC) Controlled Substances Act. Subchapter I – Control and Enforcement. Available from: https://www.deadiversion.usdoj.gov/21cfr/21usc/822.htm (accessed 27 April 2017).
  34. APRN Consensus Work Group and National Council of State Boards of Nursing APRN Advisory Committee. Consensus Model for APRN Regulation: Licensure, Accreditation, Certification, and Education. APRN Joint Dialogue Group Report, July 7, 2008. Available from: http://www.aacn.nche.edu/education-resources/APRNReport.pdf; accessed 16 February 2017).

The Journal of Haemophilia Practice is published by Haemnet.

Haemnet is a registered charity that brings together and gives a voice to haemophilia nurses, physiotherapists and allied health care professionals, providing forums for collaborative research, educational activities and support.